
CAS 956483-02-6
:Formula:C27H35N3O6
InChI:InChI=1S/C27H35N3O6/c1-4-5-6-7-17-8-10-18(11-9-17)21-12-19-14-30(27(33)29-25(19)36-21)23-13-20(31)22(35-23)15-34-26(32)24(28)16(2)3/h8-12,14,16,20,22-24,31H,4-7,13,15,28H2,1-3H3/t20-,22+,23+,24-/m0/s1
InChI key:FJRRWJMFUNGZBJ-RBVMOCNTSA-N
SMILES:CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)[C@H]4C[C@@H]([C@H](O4)COC(=O)[C@H](C(C)C)N)O
Filtra per
Percentuale di purezza
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 2 prodotti.
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
FV 100-d7 (Major)
CAS:Prodotto controllatoApplications FV 100-d7 is labelled FV 100 (F870000), an orally available nucleoside analogue prodrug of CF-1743 (C291710) which is used for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV.
References McGuigan, C., et al.: J. Med. Chem., 43, 4993 (2000); McGuigan, C., et al.: J. Antimicro. Chemother., 60, 1316 (2007); Andrei, G., et al.: Antimicro. Agents Chemother., 49, 1081 (2005)Formula:C27D7H28N3O6Colore e forma:NeatPeso molecolare:504.626Valnivudine
CAS:Valnivudine, oral BCNA antiviral, targets herpes zoster; transforms into CF-1743 in body.Formula:C27H35N3O6Purezza:98%Colore e forma:SolidPeso molecolare:497.58

